Media Centre : Newsroom
News All Investor Product Commitment Other Year All 2007 2006 2005 2004 2003 2002 2008 Language English Icelandic
Actavis today announced the launch of Bicalutamide tablets in the United Kingdom, Germany and France. Bicalutamide Actavis is the first generic version of the oncology drug to be made available in
Actavis has sold a product portfolio of 7 established brands to Glenmark Pharmaceuticals Ltd. for an undisclosed sum. The agreement with Glenmark is effective from 1 July 2008. The divestment of
Zdravlje Actavis in Serbia has been formally presented with certificates for the international standards ISO 9001:2000 (quality) and ISO 14001 (environment), as well as OHSAS 18001 (occupational
Bulgaria (Bulgarian)
Iceland (Icelandic)
Romania (Romanian)
United States